CVS Health(US:CVS) Yahoo Finance·2025-12-03 20:11Group 1 - CVS Health Corporation is recognized among the 15 Dividend Stocks that outperform the S&P 500 [1] - Wells Fargo analyst Stephen Baxter has lowered the price target for CVS to $102 from $103 while maintaining an Overweight rating, noting solid Q3 results but a tempered bullish outlook for the Health Care Benefits segment in 2025 due to a steeper Part D medical loss ratio [2] - CVS has faced challenges but is adapting to industry demands by implementing initiatives to improve margins and profitability, including online pharmacy ordering and same-day delivery [3] Group 2 - CVS continues to expand its primary care operations, highlighted by the acquisition of Oak Street Health in 2023, and launched Cordavis to reduce drug costs and improve accessibility [4] - CVS operates as a diversified healthcare company, functioning as both a healthcare provider and a pharmacy benefit manager [5]